Melatonin is often discussed as if it were a simple bedtime supplement. Jet lag is less simple. The useful question is not only whether melatonin can help, but whether its timing matches the direction of travel and the body's internal clock. A dose taken at the wrong biological time can push the clock the wrong way.[1]
Why timing changes the result
Melatonin is part of the body's darkness signal. The circadian system does not interpret it as a generic sleep switch at every hour. According to the CDC Yellow Book, melatonin taken when the internal clock thinks it is morning can create a phase delay, which may fit westward travel. Taken during the internal early evening, it can create a phase advance, which may fit eastward travel.[1]
That is why a destination bedtime is only a rough anchor. The same local clock time can represent a different biological time after a long flight. The CDC also notes that taking melatonin during the body's high-melatonin window, around 12–5 a.m., is less effective, and that poorly timed use can increase misalignment.[1]
What human studies found
A systematic review and meta-analysis of supplements for air-travel symptoms included 23 studies, 10 of them on melatonin. In the pooled analysis, melatonin was associated with lower self-reported jet-lag after eastbound travel across 5 studies and westbound travel across 4 studies. The standardised mean difference was −0.76 for eastbound travel and −0.66 for westbound travel. The confidence intervals were −1.06 to −0.45 and −1.07 to −0.26, respectively. These are group-level results for self-reported symptoms, not a promise that every traveller will adapt faster.[2]
An older Cochrane review reached a similar overall conclusion, but its detail is more useful than its headline. 9 of 10 included trials found less jet lag when melatonin was taken close to the target bedtime at the destination, around 10 p.m. to midnight, after flights crossing 5 or more time zones. In the reviewed trials, daily amounts between 0.5 and 5 mg were similarly effective, while amounts above 5 mg appeared to add no benefit. Those are study conditions, not a personal dosing plan.[3]
The direction of travel still matters
Eastward travel usually asks the body clock to move earlier; westward travel usually asks it to move later. Melatonin is not a substitute for that distinction. Light exposure, sleep timing, and the number of time zones crossed all affect the plan, which is why the CDC points travellers toward schedule-based calculators rather than one universal clock time.[1]
One small trial makes the timing issue concrete. In a double-blind study of 52 international cabin crew, an early group received 5 mg starting 3 days before arrival and continuing until 5 days after returning home. A late group received placebo for 3 days, then 5 mg for 5 days. Six days after arrival, the late group reported less jet lag and sleep disturbance than the placebo group, while the early group had worse overall recovery than placebo. The study involved a specific occupational group and an older protocol, so it is evidence for a timing question, not a universal schedule.[4]
What the evidence does not tell us
- It does not identify one best time for every itinerary, because internal clock time, destination, direction, and time-zone change differ.
- It does not show that a supplement can erase sleep loss from a flight or replace a stable sleep schedule.
- It does not make an old trial in cabin crew equivalent to evidence in every adult traveller.
- It does not turn a study amount into a recommendation for a person with a medical condition or medicine interaction.
The newer meta-analysis is encouraging, but its main outcome was self-reported jet lag. The Cochrane review is older, and several of the individual trials are small or specific to particular journeys. The fairest reading is that melatonin can help some travellers, with timing and travel direction doing much of the work.[2][3]
Product quality and short-term safety
A label is not a guarantee of exact content. The CDC cites a 2017 analysis of melatonin products sold in Canada in which measured content ranged from under 83% to over 478% of the labelled amount, and 26% of products contained serotonin as a contaminant. That finding is from a particular market and analysis, but it is a reason to treat supplement quality as part of the evidence question.[5]
A systematic review of adverse events included 37 randomised trials. Daily amounts ranged from 0.15 mg to 12 mg, monitoring lasted up to 29 weeks, and most studies lasted 4 weeks or less. The most frequently reported events were daytime sleepiness at 1.66%, headache at 0.74%, other sleep-related events at 0.74%, dizziness at 0.74%, and hypothermia at 0.62%. Few serious events were reported, but the limited long-term trial evidence makes continuous use harder to assess.[6]
The safety review says evidence is too limited to assess potentially at-risk populations well. Anyone considering melatonin alongside medicines, or with a health condition that could affect sleep or circadian timing, should check the plan with a qualified clinician or pharmacist. That is especially important when the goal is repeated use rather than a short travel episode.[6]
Bottom line
Melatonin is best understood as a time-sensitive circadian signal, not a universal sleeping pill. Research suggests it can reduce self-reported jet lag after both eastward and westward travel, but the useful timing depends on the journey and the internal clock. A careful reading keeps the benefits narrow, the product-quality caveat visible, and the limits of older and self-reported evidence in view.[2][1]
